None
Conditions
Interventions
When there is a pain relief request during labour and the woman choose for remifentanil:
Remifentanil PCA starting at 20 micrograms IV with a lock-out time of 3 minutes. When this is insufficient the
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: - Women in active phase of labour (4cm dilatation or more, 3 contracties per 10 minutes or more) - American Society of Anesthesiologists (ASA) classification I or II - Singleton term pregnancy, cephalic presentation
Exclusion criteria
Exclusion criteria: - Hypersensitivity to opioids - Women with opioid abuse or addiction - Use of opiates within 4 hours for the administration of remifentanil - Women who had epidural analgesia during this labour - Inability to provide informed consent - Simultaneous use of magnesium sulfate - Morbide obesitas (BMI >40) - Abnormal CTG for starting remifentanil, assessment according to the Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) classification.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of women receiving remifentanil PCA 20 micrograms without a dose increase during delivery. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Maternal measurements and side effects: visual analogue scale (VAS) pain score, saturation and respiratory rate. - Neonatal measurements and side effects: Apgar score, umbilical cord blood gas and necessity for the involvement of pediatrician directly postpartum due to sedation-related causes. - Patient experience with remifentanil postpartum. | — |
Contacts
Public ContactBritt Boender
Ikazia ziekenhuis
Outcome results
None listed